source:[1] AbbVie Stock Breaks Out As Its Cash Cow Lives To Fight Another Day (https://finance.yahoo.com/m/547de764-b99c-344 ...)[2] AbbVie settles with generic Rinvoq hopefuls, shielding the immunology med's US stronghold until 2037 (https://www.fiercepharma.com/pharma/abbvie-se ...)[3] AbbVie stock rises after securing patent protection for RINVOQ until 2037 - Investing.com (https://vertexaisearch.cloud.google.com/groun ...)